2020/05/27
BIOLAN and CIC bioGUNE are working together to launch a new serological test for the rapid diagnosis of COVID-19.
Science, Technology and Industry from the Basque Country to respond to the priority imposed by the pandemic: The initiative is part of a broader collaboration agreement reached between CIC bioGUNE and BIOLAN for the diagnosis of diseases and other health applications.
CIC bioGUNE and BIOLAN, a Basque biotechnology company, have started a collaboration that will allow the launch of a new serological test, BIOtest-IgG / IgM, which allows the detection of antibodies against SARS-CoV-2 quickly, easily and accurately in people who are or have been infected with the virus that causes Covid-19. The new BIOtest-IgG / IgM is a lateral flow immunochromatographic assay that can be used to diagnose patients with negative PCR and to carry out epidemiological studies to better understand the incidence and spread of the virus.
In the framework of this collaboration, BIOLAN, through OSASEN, its health division, is working on the development and production of a new lateral flow immunoassay, based on the RBD (Receptor Binding Domain) domain of spike glycoprotein of SARS-CoV-2, generated and validated by CIC bioGUNE, and in secondary monoclonal antibodies against human IgG and IgM that CIC bioGUNE is also developing.
The aim is to combine scientific knowledge of the highest level with the extensive experience of a biotechnology company to successfully launch a product developed and manufactured in the Basque Country that meets all the highest standards of reliability, precision, quality and competitiveness.
This collaborative action is part of a broader agreement reached between CIC bioGUNE and BIOLAN, both located at the Bizkaia Technology Park, in areas aimed at diagnosing diseases and other health applications that require the analysis of proteins and compounds for their use in medicine.
The agreement signed by José María Mato, CEO of CIC bioGUNE, and Asier Albizu, CEO of BIOLAN, will allow both entities to carry out R+D+i projects, provide technological services, carry out training activities, staff stays, co-supervision of Ph thesis and use of equipment of the parties in the facilities of the other.
See a large version of the first picture